Loading…
158P Neoadjuvant treatment in stage III NSCLC: Comparison with NADIM 2 trial as a gold standard
Saved in:
Published in: | ESMO open 2024-03, Vol.9, p.102913, Article 102913 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 2059-7029 2059-7029 |
DOI: | 10.1016/j.esmoop.2024.102913 |